In this episode: Why patients who stop GLP-1 therapy often return The first weeks of Medicare's obesity medication coverage The future of oral GLP-1 medications New implant technology from Novo Nordisk Muscle-preserving obesity treatments Why patient experience is becoming the next frontier in obesity medicine The goal of On The Pen has always been simple: translate complex obesity and diabetes news into information that helps you have better conversations with your doctor
During this process, older bone is removed and replaced with newer bone
For example, the Wegovy (semaglutide) prescribing information and Zepbound (tirzepatide) prescribing information describe stepwise start low and go slow titration to a maintenance dose that was tested in clinical trials and approved by regulators.[3,4] A microdose schedule is different and always off-label
GLP-1 receptors exist in skeletal muscle, where they influence glucose metabolism and energy utilization
Some patients also report changes in energy levels and mood following discontinuation, though more research is needed to fully characterize these effects
How to Take PeptideComfort for Best Results
